|Publication number||US3865108 A|
|Publication date||Feb 11, 1975|
|Filing date||Jul 9, 1973|
|Priority date||May 17, 1971|
|Publication number||US 3865108 A, US 3865108A, US-A-3865108, US3865108 A, US3865108A|
|Inventors||Hartop William L|
|Original Assignee||Ortho Pharma Corp|
|Patent Citations (10), Referenced by (156), Classifications (10) |
|External Links: USPTO, USPTO Assignment, Espacenet|
Expandable drug delivery device
US 3865108 A
A drug delivery device having a drug containing zone associated with and partially defined by a material which swells on contact with body fluids. When swelling occurs, the pressure on the drug containing zone expels the drug from the device.
111111661 @tates Fatent 1 1 [111 gamma Marion 1 Feb. 11, 1975 1 1 EXPANDABLE DRUG DIEUVERY DEVICE 2.6431027 6/1953 2.687.729 8/1965  Inventor: William L. Hartop, Bernardsvtlle, 2959250 H960 NJ. 3,102.540 9/1963 3.202.324 8/1965  Assignee. ggliitgrlllhrjrjnaceutical Corporation, 3'490454 H1970 3.559.646 2/1971  Filed: July 9, 1973 3,760,805 973 3.760.984 9/1973 Theeuwes 128/260 X  Appl. No.: 377,350
Related Application Data Primary Examiner-Richard A. Gaudet  Continuation-impart of Ser. No. 144,174, May 17. Assistant Examiner-J. C. McGowan 1971. flbandoned- Attorney, Agent, or Firm-Benjamin F. Lambert 152] 11.5. C1 128/260, 128/270, 222/95  int. CI A6111 31/00 [57 ABSTRACT  Field of Search 128/260, 127, 130. 268,
128/215, 216, 253, 213, 2 W, 2 R, 1 R, 329, A drug delivery device having a drug containing zone 330, 333, 314, 315, 270, 271, 285; 222/92, associated with and partially defined by a material 95, 206, 103, 105 which swells on contact with body fluids. When swelling occurs, the pressure on the drug containing zone (56] References Cited expels the drug from the device.
UNlTED STATES PATENTS 10 Cl 14 D F 706,778 8/1902 Pond 128/270 rawmg gums PATENIED FEB] 1 I975 SHEET 10F 2 INVENTOR Maw/n4. hM/QTOP BY mm, (1 Mg ATTORNEY I EXPANDABILE DRUG DELIVERY DEVICE This is a continuation-in-part of co-pending application Ser. No. 144,174 filed May 17,-1971, now abandoned.
Current methods of introducing medicaments such as prostaglandins, for example, into the uterine cavity for the purpose of abortion and the like require the use of in-dwelling catheters and the continual attention of medical personnel to deliver the drug by use of a syringe or by hydrostatic pressure from an outside reservoir. The device of this invention obviates the need for an indwelling catheter and, more. importantly, eliminates the need for an operator to monitor the administration of the drug.
The device of this invention comprises a generally cylindrical or prismatic base incorporating a substance which swells upon contact with natural body fluids. The base of the device either defines a hollow core containing a medicament or has disposed in a relatively restrained position around or adjacent its outer surface a medicament containing tube or sheath. In other words, the base at least partially defines a medicament containing zone of restricted dimensions. In either case, the medicament is dispensed into the body cavity due to the pressure generated on the medicament containing zone by virtue of the swelling of the base.
The invention may be better understood by reference to the attached drawings, wherein FIG. 1 is a longitudinal cross-section of a device of this invention;
FIG. 2 is a vertical cross-section of the device of FIG. 1 taken along lines 22;
FIG. 3 is a longitudinal cross-section of the device of FIGS. 1 and 2 after use;
FIG. 4 is a vertical cross-section of the used device of FIG. 3 taken along lines 4--4;
FIG. 5 is a longitudinal cross-section of another de vice of this invention;
FIG. 6 is a vertical cross-section of the device of FIG. 5 taken along lines 6-6;
FIG. 7 is a vertical cross-section of still another device of this invention illustrating the same both before and after exposure;
FIG. 8 also is a vertical cross-section of another device of this invention illustrating the same both before and after exposure;
FIG. 9 is a vertical cross-section of yet another device of this invention illustrating the same both before and after exposure;
FIG. 10 is a view in perspective of still another device of this invention;
FIG. 11 is a cross-section of the device of FIG. 10 taken along lines Ill-I1;
FIG. 12 is a vertical cross-section of another device of this invention;
FIG. 13 is a top view of another device of this invention;
FIG. 14 is a top view of yet another device of this invention.
FIGS. 1 through 11 illustrate embodiments of the invention wherein the base of the device defines a hollow medicament filled core. The device of FIGS. 1 and 2 consists ofa base, 1, formed of a material which will expand multi-directionally upon contact with body fluids, the base defining a hollow core, 2. The hollow core, 2, contains a medicament. 3, which is encased in a col- 2 lapsible tube, 4, having a closed end, 5,,projecting outward from the end, 6, of the base, I. When in use, the end of the collapsible tube is severed and the device inserted into a body cavity such as the cervix. The base, 1, will expand multi-directionally upon contact with body fluid and the resistance to expansion offered by the cervix causes the tube to collapse andthe medicament to be dispensed into the body cavity. The cervical canal is gradually enlarged to accommodate thev increased dimensions. Thus, when used to dispense a medicament for the termination of pregnancy, for example, the dilation of the cervix will facilitate the abortion.
FIGS. 3 and 4 illustrate the device of FIGS. I and 2 after use. In FIGS. 3 and 4, the capillary tube, 4, has been compressed and its contents have been expelled into the uterine cavity.
While the device may be of any shape, it is preferred that it be prismatic or cylindrical for enhancing comfort and facilitating insertion. The device also preferably has a tail, 7, to assist in its removal after use. It may also be advantageous to mold the base of the device with an enlarged end portion, 8, to prevent the device from accidentally being inserted completely into the uterus. It is not practical to give a particular dimension for the device since the size employed will depend upon whether the device is used in the nostrils, vagina, for treating rectal disorders, etc.
The base of the device is made either primarily of a material which will itself expand upon contact with body fluids, or is made of an expandable material having incorporated therein a substance which will expand upon contact with body fluids. By expandable material is meant a material which will swell or expand beyond its original or normal limits. Examples of such expandable materials include brown algae, in particular species of the genus Laminaria; polysaccharides derived from brown and red seaweeds, such as alkali metal and ammonium salts of alginic acids and carrageenan; biosynthetic polysaccharides such as xanthan gum; natural gums, such as guar gum, karaya, tragacanth, psyllium seed, and locust bean; cellulose derivatives such as microcrystallinecellulose; synthetic resins derived from cellulose, such as carboxymethylcellulose, and nonionic cellulose gums such as methylcellulose and hydroxypropyl cellulose; synthetic water-absorbing polymers such as polyvinyl alcohol, polyacrylamide, polyvinylpyrrolidone, and ethylene oxide polymers; and modified starches such as pre-gelatinized corn starch. Preferred among the expandable materials are those derived from brown algae and in particular those derived from species of the genus Laminaria.
In practice, the capillary tube may be constructed of any thin, easily collapsible metal or plastic material such as aluminum or Teflon. The material must have sufficient strength to protect the medicament during storage prior to use, but at the time of use must be eas- -ily severable and collapsible. The collapsible tube, and
the hollow core, preferably have an oval cross-section to facilitate collapse under pressure; however, any convenient shape may be utilized.
In some cases, it may be desirable to encase the base in an outer skin of highly flexible water-permeable material, 9a, such as is illustrated in FIGS. 5 and 6. Such a skin assures that the device will not break apart upon softening and swelling when in contact with body fluids. It may be advantageous to form such a skin ofa material having a high modulus of elasticity so as to exert added pressure on the medicament containing zone as the base attempts to expand.
It is possible to further improve the operation of the device by modifying the collapsible tube to prevent entrapment of the drug-due to irregular collapse of segments of the tube. Irregular collapse can be avoided by molding a longitudinal 'rib, b, inside the tube as shown in FIG. 7. Thus, the rib will allow passage of a medicament on either side of it after the tube has collapsed. This may also be accomplished by disposing ribs, 100, at each side of the tube as shown in FIG. 8. Irregular collapse may also be overcome by providing a tube with a rectangular cross-section of appropriate stiffness so that the short side walls, 11d, tend to resist collapse and thus permit passage of the drug through the spaces adjacent them as illustrated in FIG. 9.
While it was indicated at the outset that the device is preferably cylindrical or prismatic, this does not mean that the base must be formed of only one such solid. As illustrated in FIG. 10, the base may be of any shape as long as it has smooth sides and corners, and defines a hollow core into which the medicament or a capillary containing the medicament may be inserted. The device of FIG. 10 consists of a series of four rods, 101, of a material which swells when in contact with body fluids, arranged in a bundle so as to leave an open core, 102, sufficient to hold a small capillary, 104, containing the active drug, 103. The rods may be kept in their illustrated configuration by an outer water-permeable covering, 109, such as the type previously described. The expansion of the rods will fill the void occupied by the capillary and thus extrude the contents into the body cavity.
A particularly adaptable substance for a device of this design is the stalk of the seaweed of the Laminaria family which, when dried, becomes rigid and bone-like. When exposed to water, the stalk will increase in diameter nearly three-fold and become soft and flexible.
As an example of the device illustrated in FIGS. 10 and ll, and the manner in which it functions, four rods of Laminaria, each about 2V2 inches long and about A; of an inch in diameter are bound firmly together by means of fine copper wire. A catheter having an inside diameter of 0.025 inches and an outside diameter of 0.047 inches is inserted longitudinally through the space between the rods, is filled with a vegetable dye solution and one end is clamped off. When the device is immersed in water, within 12 minutes the dye solution can be observed issuing from the open end of the catheter. The dye continues to be expelled very slowly at what appears to be a uniform rate for a total of one hour and minutes. Calculations indicate that the rate of expulsion of the dye cannot have exceeded 1 X l0 ml. per minute. This rate conforms to the concept of the delivery of very small doses of highly active medicaments in a continuous fashion.
FIGS. 12 through 14 illustrate embodiments of the invention wherein the base of the device has a medicament containing tube or sheath disposed in a relatively restrained position around or adjacent its outer surface. Referring specifically to FIG. 12, the base, 201, of the device illustrated constitutes a solid core surrounded by medicament, 203, encased in a sheath,.209. The sheath is not permeable to fluids but the base absorbs body fluids through its ends thus causing the desired effect.
Referring to FIG. 13, the medicament containing tube, 304, of the device illustrated therein is helically wound around the base, 301, and anchored by passing it through the base at either end, 310. As the base expands, medicament is delivered through one of the ends, 310.
Finally, referring to FIG. 14, the medicament containing tube, 404, of the device illustrated therein is secured adjacent to the surface of the base, 401, by pass ing the same through the base at either end, 410. As the base expands, medicament is delivered through one of the ends, 410.
What is claimed is:
l. A device for the delivery of a medicament to a body cavity comprising a base, said base at least partially defining a medicament containing zone of restricted dimensions, said base being expandable and incorporating a material which expands sufficiently upon contact with body fluids to expand said base, said material being selected from the group consisting of brown algae, polysaccharides derived from brown and red seaweeds, biosynthetic polysaccharides, natural gums, cellulose derivatives, synthetic resins derived from cellulose, polyacrylamide, polyvinylpyrrolidone, ethylene oxide polymers, and modified starches, and said medicament containing zone being disposed in pressure responsive relation to said expandable base such that upon insertion of the device into a body cavity pressure is exerted on the medicament containing zone as a result of resistance to expansion by the base within the body cavity which causes the base to compress the medicament containing zone resulting in the medicament contained therein being dispensed into the body cavity.
2. The device of claim 1 wherein said base is comprised of a polymeric material and defines a hollow core which constitutes said medicament containing zone. I,
3. The device of claim 1 wherein said expandable material is Laminaria.
4. The device of claim 2 wherein said core contains a collapsible capillary tube containing said medicament.
5. The device of claim 4 in which said capillary is of oval cross-section.
6. The device of claim 1 in which a collapsible capillary tube containing said medicament is disposed in fixed position adjacent the surface of said base and the peripheral surface of said tube defining an annular medicament containing zone.
7. The device of claim 4 in which said capillary contains an inner rib along substantially its entire length.
8. The device of claim 4 in which the capillary contains a plurality of inner ribs along substantially its entire length.
9. The device of claim 4 in which the capillary tube is of rectangular cross-section.
10. The device of claim 6 in which said capillary contains an inner rib along substantially its entire length.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US706778 *||Dec 3, 1901||Aug 12, 1902||Edmund Morse Pond||Medicated tampon.|
|US2643027 *||Jul 26, 1947||Jun 23, 1953||Fink Mearl M||Uniformly collapsible tube|
|US2687729 *||Mar 7, 1951||Aug 31, 1954||Slavin William V||Medical appliance|
|US2959250 *||Sep 15, 1958||Nov 8, 1960||Minera Salvador A||Lubricant dispenser|
|US3102540 *||Jun 19, 1962||Sep 3, 1963||Bentov Itzhak E||Means for administering medicine|
|US3202324 *||Oct 5, 1962||Aug 24, 1965||Fr Des Lab Labaz Sa Soc||Plastic bags for injectable solutions|
|US3490454 *||Oct 21, 1966||Jan 20, 1970||United Merchants & Mfg||Catamenial products having a coating of rupturable microcapsules containing medicants|
|US3559646 *||Aug 16, 1968||Feb 2, 1971||Joseph Mullan||Tampon|
|US3760805 *||Jan 13, 1971||Sep 25, 1973||Alza Corp||Osmotic dispenser with collapsible supply container|
|US3760984 *||Sep 29, 1971||Sep 25, 1973||Alza Corp||Osmotically powered agent dispensing device with filling means|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3946734 *||Feb 19, 1975||Mar 30, 1976||The United States Of America As Represented By The Secretary Of State||Apparatus for controlling the release of a drug|
|US4005699 *||Oct 9, 1974||Feb 1, 1977||Louis Bucalo||Methods and apparatus for use in magnetic treatment of the body|
|US4041948 *||Jul 26, 1976||Aug 16, 1977||Johnson & Johnson||Digital tampon|
|US4185618 *||Jun 26, 1978||Jan 29, 1980||Population Research, Inc.||Promotion of fibrous tissue growth in fallopian tubes for female sterilization|
|US4192308 *||Dec 26, 1978||Mar 11, 1980||Alza Corporation||Device using prestretched polymer for dispensing medication|
|US4203440 *||Oct 23, 1978||May 20, 1980||Alza Corporation||Device having variable volume chamber for dispensing useful agent|
|US4207893 *||Dec 26, 1978||Jun 17, 1980||Alza Corporation||Device using hydrophilic polymer for delivering drug to biological environment|
|US4237893 *||Nov 28, 1979||Dec 9, 1980||Alza Corporation||Cervical dilator|
|US4299222 *||Jan 8, 1980||Nov 10, 1981||Alza Corporation||Self-contained suction pump|
|US4304232 *||Jan 28, 1980||Dec 8, 1981||Alza Corporation||Unit system having multiplicity of means for dispensing useful agent|
|US4350271 *||Aug 22, 1980||Sep 21, 1982||Alza Corporation||Water absorbing fluid dispenser|
|US4360013 *||Apr 21, 1980||Nov 23, 1982||Minnesota Mining And Manufacturing Company||Polymeric acid contraceptive devices|
|US4367741 *||Dec 22, 1980||Jan 11, 1983||Alza Corporation||Dispenser powered by cross-linked hydrophilic polymer grafted to hydrophilic polymer|
|US4455144 *||Sep 27, 1982||Jun 19, 1984||Alza Corporation||Dispenser constructed with semipermeable polymer-hydrophilic polymer wall|
|US4663148 *||Feb 14, 1986||May 5, 1987||Alza Corporation||Dispenser comprising telescopically engaging members|
|US4663149 *||Feb 14, 1986||May 5, 1987||Alza Corporation||Dispenser comprising inner and outer walls functioning as cooperative unit|
|US4692326 *||Feb 14, 1986||Sep 8, 1987||Alza Corporation||Dispenser comprising inner positioned soft or hard capsule|
|US4716031 *||Feb 12, 1986||Dec 29, 1987||Alza Corporation||Drug dispenser comprising a multiplicity of members acting together for successfully dispensing drug|
|US4764380 *||Feb 13, 1987||Aug 16, 1988||Alza Corporation||Drug delivery system comprising a volume increasing matrix containing a plurality of tiny pills|
|US4778607 *||Mar 17, 1987||Oct 18, 1988||Marathon Oil Company||Method of diluting a concentrated polymer solution for use in a hydrocarbon recovery process|
|US4800056 *||Feb 14, 1986||Jan 24, 1989||Alza Corporation||Process for making dispenser with cooperating elements|
|US4814180 *||Dec 15, 1986||Mar 21, 1989||Alza Corporation||Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container|
|US4846279 *||Jan 13, 1988||Jul 11, 1989||Marathon Oil Company||Method and means for introducing treatment fluid into a well bore|
|US4851232 *||Jun 8, 1987||Jul 25, 1989||Alza Corporation||Drug delivery system with means for obtaining desirable in vivo release rate pattern|
|US4855141 *||Mar 25, 1988||Aug 8, 1989||Alza Corporation||Device comprising means for protecting and dispensing fluid sensitive medicament|
|US4871542 *||Apr 30, 1987||Oct 3, 1989||Ferring Service Center, N.V.||Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract|
|US4931285 *||Apr 28, 1988||Jun 5, 1990||Alza Corporation||Aqueous based pharmaceutical coating composition for dosage forms|
|US4959218 *||Dec 28, 1988||Sep 25, 1990||Alza Corporation||Method for delivering somatotropin to an animal|
|US4976966 *||Dec 29, 1988||Dec 11, 1990||Alza Corporation||Delayed release osmotically driven fluid dispenser|
|US4996060 *||Apr 6, 1989||Feb 26, 1991||Alza Corporation||Device comprising liner for protecting fluid sensitive medicament|
|US5006346 *||May 11, 1989||Apr 9, 1991||Alza Corporation||Delivery system|
|US5019397 *||Apr 21, 1988||May 28, 1991||Alza Corporation||Aqueous emulsion for pharmaceutical dosage form|
|US5024663 *||Feb 21, 1990||Jun 18, 1991||Alza Corporation||Self-contained suction pump|
|US5024842 *||Apr 2, 1990||Jun 18, 1991||Alza Corporation||Annealed coats|
|US5034229 *||Dec 13, 1988||Jul 23, 1991||Alza Corporation||Dispenser for increasing feed conversion of hog|
|US5035897 *||Sep 5, 1989||Jul 30, 1991||Alza Corporation||Dosage form for delivering soluble or insoluble drugs|
|US5037420 *||Apr 20, 1990||Aug 6, 1991||Alza Corporation||Delivery system comprising two sections for delivering somatotropin|
|US5057318 *||Apr 20, 1990||Oct 15, 1991||Alza Corporation||Delivery system for beneficial agent over a broad range of rates|
|US5059423 *||Apr 23, 1990||Oct 22, 1991||Alza Corporation||Delivery system comprising biocompatible beneficial agent formulation|
|US5110596 *||Apr 20, 1990||May 5, 1992||Alza Corporation||Delivery system comprising means for delivering agent to livestock|
|US5126142 *||Jan 11, 1991||Jun 30, 1992||Alza Corporation||Dispenser comprising ionophore|
|US5135523 *||Apr 20, 1990||Aug 4, 1992||Alza Corporation||Delivery system for administering agent to ruminants and swine|
|US5137727 *||Jun 12, 1991||Aug 11, 1992||Alza Corporation||Delivery device providing beneficial agent stability|
|US5160743 *||Jan 28, 1991||Nov 3, 1992||Alza Corporation||Annealed composition for pharmaceutically acceptable drug|
|US5174999 *||Apr 20, 1990||Dec 29, 1992||Alza Corporation||Delivery system comprising fluid ingress and drug egress|
|US5180591 *||Jul 11, 1990||Jan 19, 1993||Alza Corporation||Delivery device with a protective sleeve|
|US5198229 *||Jun 5, 1991||Mar 30, 1993||Alza Corporation||Self-retaining gastrointestinal delivery device|
|US5223265 *||Jan 10, 1992||Jun 29, 1993||Alza Corporation||Osmotic device with delayed activation of drug delivery|
|US5234692 *||Sep 2, 1992||Aug 10, 1993||Alza Corporation||Delivery device with a protective sleeve|
|US5234693 *||Sep 2, 1992||Aug 10, 1993||Alza Corporation||Delivery device with a protective sleeve|
|US5234694 *||Sep 2, 1992||Aug 10, 1993||Alza Corporation||Method for increasing feed efficiency in animals|
|US5236689 *||Apr 24, 1992||Aug 17, 1993||Alza Corporation||Multi-unit delivery system|
|US5238687 *||Sep 2, 1992||Aug 24, 1993||Alza Corporation||Delivery device with a protective sleeve|
|US5240713 *||Sep 27, 1991||Aug 31, 1993||Alza Corporation||Dual rate agent delivery device|
|US5273752 *||Sep 19, 1991||Dec 28, 1993||Alza Corporation||Controlled release dispenser comprising beneficial agent|
|US5282785 *||Oct 5, 1992||Feb 1, 1994||Cortrak Medical, Inc.||Drug delivery apparatus and method|
|US5286254 *||Aug 28, 1992||Feb 15, 1994||Cortrak Medical, Inc.||Drug delivery apparatus and method|
|US5312390 *||Jan 14, 1993||May 17, 1994||Alza Corporation||Osmotic device with delayed activation of drug delivery|
|US5320616 *||Nov 7, 1991||Jun 14, 1994||Alza Corporation||Delivery system comprising first walled section and second walled section united by fusion, adhesion or telescopic engagement|
|US5340590 *||Jul 8, 1993||Aug 23, 1994||Alza Corporation||Delivery system with bilayer osmotic engine|
|US5391381 *||May 11, 1993||Feb 21, 1995||Alza Corporation||Dispenser capable of delivering plurality of drug units|
|US5443459 *||Aug 19, 1993||Aug 22, 1995||Alza Corporation||Osmotic device for delayed delivery of agent|
|US5458568 *||Sep 17, 1993||Oct 17, 1995||Cortrak Medical, Inc.||Porous balloon for selective dilatation and drug delivery|
|US5474785 *||Jul 15, 1993||Dec 12, 1995||Alza Corporation||Delivery system comprising means for controlling internal pressure|
|US5498238 *||Aug 27, 1993||Mar 12, 1996||Cortrak Medical, Inc.||Simultaneous angioplasty and phoretic drug delivery|
|US5498255 *||May 15, 1995||Mar 12, 1996||Alza Corporation||Osmotic device for protracted pulsatile delivery of agent|
|US5536243 *||Dec 13, 1994||Jul 16, 1996||Jeyendran; Rajasingam S.||Time-release insemination device|
|US5628730 *||Jul 18, 1994||May 13, 1997||Cortrak Medical, Inc.||Phoretic balloon catheter with hydrogel coating|
|US5630808 *||Mar 1, 1994||May 20, 1997||Alza Corporation||Delivery system comprising means for governing fluid into the system and for restricting fluid into the system|
|US5690952 *||Jun 7, 1995||Nov 25, 1997||Judy A. Magruder et al.||Implantable system for delivery of fluid-sensitive agents to animals|
|US5707663 *||May 16, 1995||Jan 13, 1998||Alza Corporation||Sustained antiepileptic therapy|
|US5714160 *||Apr 3, 1996||Feb 3, 1998||Alza Corporation||Delivery system comprising means for governing fluid ingress into the system|
|US5728088 *||Jul 1, 1994||Mar 17, 1998||Alza Corporation||Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals|
|US5773020 *||Oct 28, 1997||Jun 30, 1998||Vivus, Inc.||Treatment of erectile dysfunction|
|US5800422 *||Aug 8, 1996||Sep 1, 1998||Alza Corporation||Osmotic device with delayed activation of drug delivery and complete drug release|
|US5807306 *||Aug 16, 1994||Sep 15, 1998||Cortrak Medical, Inc.||Polymer matrix drug delivery apparatus|
|US5817335 *||May 26, 1995||Oct 6, 1998||Alza Corporation||Osmotic device with high drug loading and delayed activation of drug delivery|
|US5861166 *||Sep 30, 1993||Jan 19, 1999||Alza Corporation||Delivery device providing beneficial agent stability|
|US5871770 *||Oct 8, 1997||Feb 16, 1999||Alza Corporation||Implantable system for delivery of fluid-sensitive agents to animals|
|US5902605 *||Apr 18, 1997||May 11, 1999||Alza Corporation||Drug delivery device with minimal residual drug retention|
|US5922353 *||Oct 8, 1997||Jul 13, 1999||Alza Corporation||Interlocking couplings for osmotic delivery devices|
|US5938654 *||Feb 1, 1995||Aug 17, 1999||Alza Corporation||Osmotic device for delayed delivery of agent|
|US5980509 *||Nov 24, 1997||Nov 9, 1999||Alza Corporation||Osmotic system for delivery of fluid-sensitive somatotropins to bovine animals|
|US5980943 *||Oct 21, 1997||Nov 9, 1999||Alza Corporation||Sustained antiepileptic therapy|
|US5988169 *||Mar 29, 1996||Nov 23, 1999||Iotek, Inc.||Vaginal insert and method for treating urogenital disorders|
|US6030375 *||Mar 29, 1996||Feb 29, 2000||Iotek, Inc.||Compressible vaginal insert and method for treating urogenital disorders|
|US6120484 *||Apr 7, 1999||Sep 19, 2000||Silverstein; Herbert||Otological implant for delivery of medicament and method of using same|
|US6152943 *||Aug 14, 1998||Nov 28, 2000||Incept Llc||Methods and apparatus for intraluminal deposition of hydrogels|
|US6153678 *||Oct 6, 1998||Nov 28, 2000||Alza Corporation||Injection-moldable composition and article of manufacture comprising same|
|US6159491 *||Feb 12, 1999||Dec 12, 2000||Biovector Technologies, Inc.||Prolonged release bioadhesive vaginal gel dosage form|
|US6165201 *||Sep 3, 1999||Dec 26, 2000||Incept Llc||Method and apparatus for in situ formation of hydrogels|
|US6179862||Aug 14, 1998||Jan 30, 2001||Incept Llc||Methods and apparatus for in situ formation of hydrogels|
|US6180129||Oct 23, 1997||Jan 30, 2001||Alza Corporation||Polyurethane-containing delivery systems|
|US6270799||Sep 15, 1998||Aug 7, 2001||Bayer Aktiengesellscahft||Medicament formulation with a controlled release of an active agent|
|US6287598||May 28, 1993||Sep 11, 2001||Alza Corporation||Method for providing sustained antiepileptic therapy|
|US6342249||Dec 22, 1999||Jan 29, 2002||Alza Corporation||Controlled release liquid active agent formulation dosage forms|
|US6379373||Sep 3, 1999||Apr 30, 2002||Confluent Surgical, Inc.||Methods and apparatus for intraluminal deposition of hydrogels|
|US6510561||Oct 20, 1999||Jan 28, 2003||Reckitt Benckiser (Uk) Limited||Dispensing device|
|US6558362||Feb 2, 2000||May 6, 2003||Bernard Chaffringeon||Disposable device for transferring an active liquid into a body cavity|
|US6596314||Dec 14, 2001||Jul 22, 2003||Alza Corporation||Controlled release liquid active agent formulation dosage forms|
|US6605294||Aug 14, 1998||Aug 12, 2003||Incept Llc||Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels|
|US6632457||Aug 14, 1998||Oct 14, 2003||Incept Llc||Composite hydrogel drug delivery systems|
|US6673093||Apr 21, 2000||Jan 6, 2004||Incept Llc||Methods and apparatus for in situ formation of hydrogels|
|US6706282||Nov 1, 1999||Mar 16, 2004||Evangeline Cruz||Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones|
|US6855334||Nov 27, 2001||Feb 15, 2005||Alta Corporation||Controlled delivery of active agents|
|US7220270||Jan 13, 2004||May 22, 2007||Incept Llc||Methods and apparatus for intraluminal deposition of hydrogels|
|US7398780||Oct 25, 2004||Jul 15, 2008||Ams Research Corporation||Contraceptive system and method of use|
|US7413752||Aug 12, 2003||Aug 19, 2008||Incept Llc||Composite hydrogel drug delivery systems|
|US7611494||Feb 8, 2005||Nov 3, 2009||Confluent Surgical, Inc.||Spray for fluent materials|
|US7648713||Jul 9, 2003||Jan 19, 2010||Incept Llc||Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels|
|US7694683 *||Jun 28, 2004||Apr 13, 2010||Conceptus, Inc.||Methods and devices for occluding body lumens and/or for delivering therapeutic agents|
|US7713550||Jun 15, 2004||May 11, 2010||Andrx Corporation||Controlled release sodium valproate formulation|
|US7776063||Dec 21, 2007||Aug 17, 2010||Incept Llc||In situ materials formation|
|US7780980||Apr 19, 2006||Aug 24, 2010||Incept, Llc||Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels|
|US7914541||Apr 13, 2007||Mar 29, 2011||Incept, Llc||In situ materials formation|
|US7922702||Jul 1, 2005||Apr 12, 2011||Qlt Inc.||Treatment medium delivery device and methods for delivery of such treatment mediums to the eye using such a delivery device|
|US7998497||Apr 2, 2007||Aug 16, 2011||Qlt Inc.||Nasolacrimal drainage system implants for drug therapy|
|US8075872||Feb 6, 2006||Dec 13, 2011||Gruenenthal Gmbh||Abuse-proofed dosage form|
|US8084059||Sep 15, 2006||Dec 27, 2011||Alza Corporation||Antidepressant dosage form|
|US8105622||Aug 8, 2007||Jan 31, 2012||Incept Llc||Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels|
|US8113205||Feb 21, 2008||Feb 14, 2012||Conceptus, Inc.||Contraceptive system and method of use|
|US8114383||Nov 20, 2003||Feb 14, 2012||Gruenenthal Gmbh||Abuse-proofed dosage form|
|US8114384||Jul 14, 2004||Feb 14, 2012||Gruenenthal Gmbh||Process for the production of an abuse-proofed solid dosage form|
|US8152777||Nov 2, 2009||Apr 10, 2012||Confluent Surgical, Inc.||Spray for fluent materials|
|US8192722||Jun 17, 2008||Jun 5, 2012||Grunenthal Gmbh||Abuse-proof dosage form|
|US8226979||Apr 11, 2011||Jul 24, 2012||Alza Corporation||Drug coating providing high drug loading and methods for providing the same|
|US8235047||Mar 30, 2006||Aug 7, 2012||Conceptus, Inc.||Methods and devices for deployment into a lumen|
|US8246986||Sep 23, 2004||Aug 21, 2012||Alza Corporation||Drug coating providing high drug loading|
|US8309060||Jan 9, 2012||Nov 13, 2012||Grunenthal Gmbh||Abuse-proofed dosage form|
|US8323889||Jun 17, 2008||Dec 4, 2012||Gruenenthal Gmbh||Process for the production of an abuse-proofed solid dosage form|
|US8333726||Sep 8, 2008||Dec 18, 2012||Qlt Inc.||Lacrimal implants and related methods|
|US8383152||Jan 23, 2009||Feb 26, 2013||Gruenenthal Gmbh||Pharmaceutical dosage form|
|US8383161||Dec 15, 2010||Feb 26, 2013||Incept, Llc||Radioopaque covalently crosslinked hydrogel particle implants|
|US8394644 *||Nov 8, 2007||Mar 12, 2013||Honeywell International Inc.||Microfluidic osmotic pump|
|US8409606||Feb 12, 2010||Apr 2, 2013||Incept, Llc||Drug delivery through hydrogel plugs|
|US8420056||Oct 11, 2011||Apr 16, 2013||Grunenthal Gmbh||Abuse-proofed dosage form|
|US8434489||Oct 23, 2009||May 7, 2013||Conceptus, Inc.||Contraceptive devices and methods|
|US8524749||Jan 16, 2008||Sep 3, 2013||Alza Corporation||Controlled release compositions of tizanidine|
|US8535653||Nov 6, 2003||Sep 17, 2013||Reckitt Benckiser (Uk) Limited||Articles for the release or emanation of vapors|
|US8541026||Apr 20, 2007||Sep 24, 2013||Abbvie Inc.||Sustained release formulations of opioid and nonopioid analgesics|
|USRE35601 *||Aug 11, 1994||Sep 2, 1997||Alza Corporation||Delivery device providing beneficial agent stability|
|DE3634864A1 *||Oct 13, 1986||Apr 14, 1988||Alza Corp||Abgabevorrichtung zur freisetzung einer auf temperatur ansprechenden masse|
|EP0168507A1 *||Jul 14, 1984||Jan 22, 1986||Repromed, Inc.||Osmotic cervical dilator|
|EP1652516A2||Oct 26, 1999||May 3, 2006||ALZA Corporation||Osmotic controlled delivery of active agents|
|EP2154241A2||Aug 12, 2009||Feb 17, 2010||The Regents of the University of Michigan||Cell culture well-plates having inverted colloidal crystal scaffolds|
|EP2335691A1||Apr 29, 2005||Jun 22, 2011||Bayer Schering Pharma AG||Formulations comprising vardenafil with controlled release of active ingredient|
|EP2529730A1||Jun 16, 2004||Dec 5, 2012||ANDRX Pharmaceuticals LLC.||Oral sustained-release composition|
|EP2535042A1||Jun 16, 2004||Dec 19, 2012||ANDRX Pharmaceuticals LLC.||Oral sustained-release composition comprising a macrolide|
|WO1984000494A1 *||Jul 5, 1983||Feb 16, 1984||Health Prod Res||Dilatation device for the cervix|
|WO2000023663A1||Oct 20, 1999||Apr 27, 2000||Hammond Geoffrey Robert||Dispensing device|
|WO2004043501A1||Nov 6, 2003||May 27, 2004||Malcolm Tom Mckechnie||Improvements in or relating to articles|
|WO2004048451A2||Nov 26, 2003||Jun 10, 2004||Genencor Int||Optical information carrier comprising immobilized proteorhodopsin|
|WO2008084698A1||Dec 26, 2007||Jul 17, 2008||Astellas Pharma Inc||Tacrolimus sustained release pharmaceutical composition|
|WO2011049694A1||Sep 16, 2010||Apr 28, 2011||Conceptus, Inc.||Contraceptive devices|
|WO2011122524A1||Mar 28, 2011||Oct 6, 2011||Astellas Pharma Inc.||Controlled release pharmaceutical composition|
|WO2012025930A2 *||Aug 25, 2011||Mar 1, 2012||Ocure Ltd.||Medical instruments of treating and/or diagnosing of anorectal disorders, and devices and methods for insertion of such|